FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Bosentan Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Janssen Research and Development, LLC (New 10/15/2019)

Company Contact Information:
800-526-7736

Presentation Posting Date Related Information
62.5 mg tablets (NDC 10148-625-60) 10/15/2019
125 mg tablets (NDC 10148-125-60) 10/15/2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English